From a Pathophysiological Concept to a New Drug von Németh, G.

Volltext

Origins and consequences of asymmetric nano-FTIR interferograms von Németh, G, Bechtel, H A, Borondics, Ferenc

Volltext

Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus von Németh, Christopher G, Röcken, Christoph, Siebert, Reiner, Wiltfang, Jörg, Ammerpohl, Ole, Gassling, Volker

Volltext

Exploring Cariprazine’s Potential in Late-Stage Schizophrenia Treatment von Falkai, P, Csehi, R, Acsai, K, Németh, G

Volltext

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials von McIntyre, R. S., Csehi, R., Németh, G.

Volltext

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence von Rancans, E., Dombi, Z. B., Csehi, R., Németh, G.

Volltext

OP14.07: Identifying weak points of pelvic floor by sonoelastography in case of stress incontinence von Csákány, L., Pásztor, N., Németh, G., Várbíró, S., Suranyi, A.

Volltext

Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials von Mcintyre, R., Dombi, Z., Barabássy, Á., Németh, G.

Volltext

EP09.111: Ultrasound examination of fetal myocardium to screen out pregnancy complication in gestational diabetes mellitus von Suranyi, A., Pál, Z., Kádas, Z., Várbíró, S., Németh, G., Kozinszky, Z.

Volltext

The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials von Falkai, P., Dombi, Z., Acsai, K., Barabássy, Á., Németh, G.

Volltext

The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders von Barabássy, Á, Dombi, Z B, Csehi, R, Djuric, D, Németh, G

Volltext

Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase von Vass, G., Barabássy, Á., Laszlovszky, I., Sebe, B., Dombi, Z.B., Szatmári, B., Németh, G.

Volltext

Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials von Dombi, Z.B., Acsai, K., Barabássy, Á., Sebe, B., Laszlovszky, I., Vass, G., Szatmári, B., Patel, M., Earley, W., Németh, G.

Volltext

The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia von Laszlovszky, I., Dombi, Z.B., Balogh, Á., Barabássy, Á., Vass, G., Szatmári, B., Németh, G.

Volltext

Angiogenic factors measured in aspirated placental tissue between the 10 + 6 and 18 + 3 weeks of gestation von Sikovanyecz, János, Vincze, Márió, Földesi, Imre, Németh, Gábor, Kozinszky, Zoltan

Volltext

Safety and efficacy of cariprazine in FDA-approved dose ranges for schizophrenia and bipolar I disorder: a pooled post hoc analysis von Earley, W, Durgam, S, Lu, K, Németh, G, Edwards, J, Laszlovszky, I

Volltext

Spinal stenosis re-operation rate in Sweden is 11% at 10 years--a national analysis of 9,664 operations von Jansson, Karl-Ake, Németh, Gunnar, Granath, F, Blomqvist, P

Volltext

Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials von Durgam, S, Earley, W, Lu, K, Németh, G, Laszlovszky, I, Szatmári, B, Edwards, J, Nasrallah, H.A

Volltext

Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition von Marder, S, Laszlovszky, I, Szalai, E, Szatmári, B, Harsányi, J, Barabássy, A, Debelle, M, Durgam, S, Bitter, I, Németh, G

Volltext

P.3.d.053 Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial von Debelle, M, Németh, G, Szalai, E, Szatmári, B, Harsányi, J, Barabassy, A, Laszlovszky, I

Volltext